Malignant Breast Neoplasm — Trials

Malignant Breast Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

12,355 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,627
Recruiting: 1,396
Ph III recruiting: 150
Growth YoY: +23%
Industry share: 18%
Top sponsor: Fudan University
Termination share: 25.6%
Trials / 1,000 deaths: 61.5 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,367)

clinicaltrialsPublishedShowing 1–50 of 1,767 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06955156	Trilaciclib Combined With Anti-PD-1 Antibody and Chemotherapy in the Treatment of Locally Advanced TNBC	unknown	Phase 2	50	QIAO LIOTHER	1	May 2, 2025	clinicaltrials
NCT04097366	Breast Screening - Risk Adaptive Imaging for Density(BRAID)	unknown	N/A	9,000	University of CambridgeOTHER	1	Mar 30, 2025	clinicaltrials